Management of Persistent GERD with Dysphagia

Diagnostic Approach

The American College of Physicians recommends that patients with GERD symptoms and dysphagia undergo immediate upper endoscopy to rule out esophageal stricture, malignancy, or eosinophilic esophagitis, as dysphagia is an alarm symptom that requires urgent evaluation regardless of PPI response 1
The American Gastroenterological Association suggests that the complete endoscopic evaluation must assess erosive esophagitis, esophageal stricture, Barrett's esophagus, hiatal hernia, and eosinophilic esophagitis, with the use of Los Angeles classification for erosive esophagitis and Prague classification for Barrett's esophagus 2

The American College of Gastroenterology recommends escalating to twice-daily PPI therapy immediately if the patient is currently on once-daily dosing, as persistent heartburn indicates inadequate acid suppression, with a standard dosing of omeprazole 20 mg twice daily or equivalent 2, 3
The guideline suggests not exceeding 8 weeks of empirical therapy without objective testing, and continuing twice-daily PPI therapy after dilation if a stricture is found 3, 1

The American College of Physicians recommends dilation for symptomatic relief if a stricture is found, and continuing twice-daily PPI therapy after dilation 1
The American Gastroenterological Association suggests continuing twice-daily PPI for 8 weeks if severe erosive esophagitis (LA Grade C or D) is found, and repeating endoscopy after 2 months to confirm healing and rule out Barrett's esophagus 2, 1

The American College of Gastroenterology recommends weight loss if BMI >25, elevating the head of bed 6-8 inches for nighttime symptoms, avoiding meals within 3 hours of bedtime, and eliminating trigger foods identified by patient history 2, 3

The American College of Surgeons suggests considering surgical or endoscopic intervention (laparoscopic fundoplication, magnetic sphincter augmentation, or transoral incisionless fundoplication) for proven GERD with persistent regurgitation despite optimized PPI therapy, particularly in carefully selected patients with documented hiatal hernia and intact esophageal motility 2, 5, 4